Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): David Antoniucci Added: 3 years ago
In the setting of acute myocardial infarction (AMI), spontaneous and percutaneous coronary intervention (PCI)-related embolisation results in a decreased efficacy of mechanical reperfusion and myocardial salvage. Direct stenting without predilation may decrease embolisation and the incidence of the no-reflow phenomenon.1,2 More specific approaches to the problem of microvessel embolisation during… View more

MI/ACS

Intervention
Association of Hyperhomocysteinemia with Acute Myocardial Infarction in Iraqi Patients
Author(s): S Othman Amen , Soza Tharwat Mohammed Baban Added: 3 years ago
Background: Coronary artery disease (CAD) and its major manifestation acute MI (AMI) are the most common causes of death worldwide. Hyperhomocysteinemia (HHcy) has been recently recognised as a new emerging cardiovascular risk factor mediating in development of CAD risk. HHcy causes endothelial dysfunction, resulting in local thrombosis and subsequent ischaemia. However, the role of HHcy in… View more

Prevention & Chronic Conditions

MI/ACS
Author(s): Roberto Sciagrà Added: 3 years ago
The best possible outcome in acute myocardial infarction (AMI) is the absence of any residual myocardial damage. This condition, usually obtained by early and effective reperfusion therapy, has been defined as aborted infarction.1 The classic diagnosis of aborted infarction is based on the detection of a minimal increase in cardiac enzymes together with a favourable evolution of the… View more

Heart Failure
Author(s): Miriam Reiter , Tobias Reichlin , Raphael Twerenbold , et al Added: 3 years ago
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide. Accordingly, prompt identification of patients with AMI is critical, as established therapies exist that are of proven benefit.1,2 More than 15 million patients per year present to emergency departments with symptoms compatible with acute myocardial ischaemia in the US and Europe; only 20–30%, however, are… View more

Heart Failure
ESC 2017: Role of Oxygen in Suspected Acute Myocardial Infarction (DETOX)
Author(s): Robin Hofmann Added: 6 years ago
This interview with Robin Hofmann from Karolinska Institutet, Stockholm, SE discusses Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction (DETOX) at ESC 2017. Filmed by Radcliffe Cardiology on-site . View more

MI/ACS
ESC 22: PACIFIC-AMI: FXIa Inhibitor on Top of DAPT After AMI
Author(s): John Alexander Added: 1 year ago
ESC Congress 22 — Dr John HP Alexander (Duke University Medical Center, US) joins us to share the latest data from the PACIFIC-AMI trial (NCT04304534). This multicenter, randomized, placebo-controlled, double-blind and dose-finding phase 2 study assessed the efficacy and safety of asundexian (Bayer), an oral FXIa inhibitor on top of a dual antiplatelet therapy (ASA + P2Y12 inhibitor) in… View more

Anticoagulation

Vascular Disease and Surgery
Author(s): Ronald K Binder , Ahmed A Khattab Added: 3 years ago
The treatment of acute myocardial infarction (AMI) has substantially improved in recent decades. Thrombolysis, the former first-line therapy, which is inexpensive and may be administered without noteworthy delay in primary care or pre-hospital settings, has been replaced by primary percutaneous coronary intervention (PCI) despite the inherent delay of transfering patients to a cardiac… View more

Imaging & Diagnostics

MI/ACS
Author(s): Christian Spaulding Added: 3 years ago
Currently, the optimal treatment of acute myocardial infarction (AMI) in patients presenting with ST-segment-elevation MI (STEMI) is to perform a primary percutaneous coronary intervention (PCI) as quickly as possible after onset of symptoms.1,2 While this has become the standard of care for treating AMI, several factors, including limited availability of catheterisation laboratories in a… View more

MI/ACS

Intervention
EP 103: CCS-AMI: New Classification for Acute Myocardial Infarction with Dr Kumar
Author(s): Ankur Kalra , Andreas Kumar Added: 5 months ago
On October 28th, 2023, the Canadian Cardiovascular Society (CCS) released a new classification system for acute atherothrombotic myocardial infarction (MI) based on stages of tissue injury severity (CCS-AMI). This expert consensus is the result of decades of data on acute MI with reperfusion therapy. Dr Ankur Kalra is joined this week on Parallax by Dr Andreas Kumar, Chairperson of the Writing… View more

Imaging & Diagnostics

MI/ACS
Association of Vitamin D Deficiency with Acute Myocardial Infarction in Iraqi Patients
Author(s): S Othman Amen , Soza Tharwat Mohammed Baban Added: 3 years ago
Background: Globally, coronary artery disease (CAD) and its complications, such as acute myocardial infarction (AMI), are the leading cause of morbidity and mortality. Vitamin D deficiency is a prevalent condition and it is emerging as a new risk factor for CAD. However, the correlation between vitamin deficiency and an increased risk of developing cardiovascular disease remains elusive. Aim: To… View more

Prevention & Chronic Conditions

MI/ACS